We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+21.39%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$2.5B
AUM Growth
+$482M
Cap. Flow
+$84.9M
Cap. Flow %
3.4%
Top 10 Hldgs %
30.71%
Holding
250
New
26
Increased
102
Reduced
86
Closed
11

Top Buys

Rank Stock Value
1
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$18.6M
2
XYL icon
Xylem
XYL
+$13.8M
3
HD icon
Home Depot
HD
+$13.6M
4
ISTB icon
iShares Core 1-5 Year USD Bond ETF
ISTB
+$13.1M
5
SEIC icon
SEI Investments
SEIC
+$11.6M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
2
JPIN icon
JPMorgan Diversified Return International Equity ETF
JPIN
+$13.7M
3
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$10.6M
4
AMZN icon
Amazon
AMZN
+$10.5M
5
WFC icon
Wells Fargo
WFC
+$4.05M

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Financials 15.24%
3 Healthcare 10.98%
4 Consumer Discretionary 7.31%
5 Communication Services 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UMH
226
UMH Properties
UMH
$1.3B
$180K 0.01%
13,896
– –
CDMO
227
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$164K 0.01%
25,000
-5,000
-17% -$27.9K
AGEN
228
Agenus
AGEN
$329M
$129K 0.01%
1,678
– –
MTNB icon
229
Matinas BioPharma
MTNB
$2.03M
$110K ﹤0.01%
2,850
– –
EARN
230
Ellington Residential Mortgage REIT
EARN
$168M
$103K ﹤0.01%
+10,000
New +$89.9K
F icon
231
Ford
F
$59.3B
$70K ﹤0.01%
11,500
– –
APHA
232
DELISTED
Aphria Inc. Common Shares
APHA
$54K ﹤0.01%
12,500
– –
NOK icon
233
Nokia
NOK
$50.7B
$44K ﹤0.01%
10,000
– –
DAKT icon
234
Daktronics
DAKT
$941M
$41K ﹤0.01%
40,989
– –
CATX icon
235
Perspective Therapeutics
CATX
$341M
$30K ﹤0.01%
5,482
– –
HTT
236
High Templar Tech Ltd
HTT
$379M
$20K ﹤0.01%
+12,050
New +$19.9K
FSTX
237
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$19K ﹤0.01%
3,204
-625
-16% -$3.61K
PTN
238
Palatin Technologies
PTN
$13.9M
$13K ﹤0.01%
20
– –
CUE icon
239
Cue Biopharma
CUE
$128M
– –
-9,000
Closed -$3.83M
DIA icon
240
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.5B
– –
-2,612
Closed -$573K
IGV icon
241
iShares Expanded Tech-Software Sector ETF
IGV
$12.5B
– –
-36,225
Closed -$1.52M
IWS icon
242
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
– –
-3,125
Closed -$200K
PI icon
243
Impinj
PI
$4.49B
– –
-11,120
Closed -$186K
SAN icon
244
Banco Santander
SAN
$202B
– –
-86,097
Closed -$194K
UL icon
245
Unilever
UL
$141B
– –
-43,338
Closed -$2.47M
VOE icon
246
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
– –
-3,190
Closed -$259K
XLV icon
247
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
– –
-3,638
Closed -$322K
FBGX
248
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
– –
-866
Closed -$201K
RTN
249
DELISTED
Raytheon Company
RTN
– –
-2,302
Closed -$302K
6 7 8 9
10

Similar funds

AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
GFM
GF Fund Management Guangzhou, China $5.98B AUM 80.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Crestwood Advisors Group's Q2 2020 Portfolio in Review

As of Q2 2020, Crestwood Advisors Group held 250 positions worth $2.5B, up 24% from $2.02B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Crestwood Advisors Group deployed $84.9M of net new capital in Q2 2020, opening 26 new positions and adding to 102 existing holdings. Its largest new stake was Xylem: 208,372 shares worth $13.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $15.7M trimmed.

  • Crestwood Advisors Group's largest Q2 2020 buy was Xylem: 208,372 shares worth $13.5M.
  • Crestwood Advisors Group added most to iShares Core MSCI EAFE ETF in Q2 2020, an estimated $18.6M increase.
  • Crestwood Advisors Group's biggest Q2 2020 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $15.7M.
  • Crestwood Advisors Group fully exited Cue Biopharma in Q2 2020, selling an estimated $3.83M.
  • Crestwood Advisors Group's ten largest holdings make up 31% of its $2.5B portfolio in Q2 2020.
  • Crestwood Advisors Group opened 26 new positions and closed 11 in Q2 2020.
  • Crestwood Advisors Group's portfolio value rose 24% quarter-over-quarter to $2.5B.

Based on Crestwood Advisors Group's 13F filing for Q2 2020, filed 14 Aug 2020.